Table of Contents

Global RNA Drugs Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 siRNA -Product Introduction and Major Manufacturers
1.1.2 ASO -Product Introduction and Major Manufacturers
1.1.3 miRNA -Product Introduction and Major Manufacturers
1.1.4 Nucleic Acid Aptamers -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China RNA Drugs Status and Prospect (2015-2026)
2.1.1 China RNA Drugs Market Size and Growth Rate (2015-2026)
2.1.2 China RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU RNA Drugs Status and Prospect (2015-2026)
2.2.1 EU RNA Drugs Market Size and Growth Rate (2015-2026)
2.2.2 EU RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA RNA Drugs Status and Prospect (2015-2026)
2.3.1 USA RNA Drugs Market Size and Growth Rate (2015-2026)
2.3.2 USA RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan RNA Drugs Status and Prospect (2015-2026)
2.4.1 Japan RNA Drugs Market Size and Growth Rate (2015-2026)
2.4.2 Japan RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India RNA Drugs Status and Prospect (2015-2026)
2.5.1 India RNA Drugs Market Size and Growth Rate (2015-2026)
2.5.2 India RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia RNA Drugs Status and Prospect (2015-2026)
2.6.1 Southeast Asia RNA Drugs Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America RNA Drugs Status and Prospect (2015-2026)
2.7.1 South America RNA Drugs Market Size and Growth Rate (2015-2026)
2.7.2 South America RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 RNA Drugs Status and Prospect (2015-2026)
2.8.1 RNA Drugs Market Size and Growth Rate (2015-2026)
2.8.2 RNA Drugs Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global RNA Drugs Market Assessment by Segment
3.1 Global RNA Drugs Capacity and Growth Rate
3.2 Global RNA Drugs Sales by Type
3.3 Global RNA Drugs Sales Revenue by Type
3.4 Global RNA Drugs Consumption by Application
4 Global RNA Drugs Market Assessment by Regions
4.1 Global RNA Drugs Production Analysis and Forecast by Regions (2015-2026)
4.2 Global RNA Drugs Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global RNA Drugs Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 RNA Drugs Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on RNA Drugs Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global RNA Drugs Capacity Market Share of Manufacturers (2019-2020)
6.2 Global RNA Drugs Sales Market Share of Manufacturers (2019-2020)
6.3 Global RNA Drugs Sales Revenue Market Share of Manufacturers (2019-2020)

7 RNA Drugs Competitive Analysis
7.1 Pfizer
7.1.1 Pfizer Company Profiles
7.1.2 Pfizer Product Introduction
7.1.3 Pfizer RNA Drugs Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Roche
7.2.1 Roche Company Profiles
7.2.2 Roche Product Introduction
7.2.3 Roche RNA Drugs Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Company Profiles
7.3.2 Sanofi-Aventis Product Introduction
7.3.3 Sanofi-Aventis RNA Drugs Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Company Profiles
7.4.2 Abbott Laboratories Product Introduction
7.4.3 Abbott Laboratories RNA Drugs Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Arrowhead Pharmaceuticals
7.5.1 Arrowhead Pharmaceuticals Company Profiles
7.5.2 Arrowhead Pharmaceuticals Product Introduction
7.5.3 Arrowhead Pharmaceuticals RNA Drugs Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 Benitec Biopharma
7.6.1 Benitec Biopharma Company Profiles
7.6.2 Benitec Biopharma Product Introduction
7.6.3 Benitec Biopharma RNA Drugs Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Calimmune Inc
7.7.1 Calimmune Inc Company Profiles
7.7.2 Calimmune Inc Product Introduction
7.7.3 Calimmune Inc RNA Drugs Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Dicerna
7.8.1 Dicerna Company Profiles
7.8.2 Dicerna Product Introduction
7.8.3 Dicerna RNA Drugs Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Gradalis
7.9.1 Gradalis Company Profiles
7.9.2 Gradalis Product Introduction
7.9.3 Gradalis RNA Drugs Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Quark
7.10.1 Quark Company Profiles
7.10.2 Quark Product Introduction
7.10.3 Quark RNA Drugs Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 RXi
7.12 Senesco
7.13 Silence Therapeutics
7.14 Silenseed
7.15 Tekmira
7.16 Alnylam Pharmaceuticals
8 Conclusion

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.